Third-line therapy and beyond for patients with advanced/metastatic non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Corral Jaime, Jesus [1 ]
Gonzalez de la Pena, Miriam [1 ]
Alonso, Miriam [1 ]
Sanchez Gastaldo, Amparo [1 ]
Dolores Mediano, Maria [1 ]
Amerigo, Marta [1 ]
Enrique Robles, Carlos [1 ]
机构：
[1] Hosp Univ Virgen Rocio, Seville, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19160
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Third-line therapy in advanced non-small cell lung cancer
    Geng, Zhen Ying
    Jiao, Shun Chang
    Liu, Shi Cui
    Li, Ying
    Liu, Zhe Feng
    Zhang, Guo Qing
    Wang, Li Jie
    Qu, Feng
    JOURNAL OF BUON, 2013, 18 (04): : 899 - 907
  • [2] Prevalence and effectiveness of third-line therapy for advanced non-small cell lung cancer (A-NSCLC)
    Ferreira, Catarina
    Fernandes, Ligia
    Figueiredo, Ana
    Barata, Fernando
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [3] Third-line chemotherapy with gemcitabine or docetaxel in patients with advanced non-small cell lung cancer (NSCLC).
    Morgensztern, D
    Lim, WT
    Subramanian, J
    Viswanathan, A
    Govindan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 694S - 694S
  • [4] Clinical predictive factors for advanced non-small cell lung cancer (NSCLC) patients receiving third-line therapy: Selecting the unselectable?
    Scartozzi, Mario
    Mazzanti, Paola
    Giampieri, Riccardo
    Berardi, Rossana
    Galizia, Eva
    Gasparini, Stefano
    Zuccatosta, Lina
    Cascinu, Stefano
    LUNG CANCER, 2010, 68 (03) : 433 - 437
  • [5] Third-line Therapy And Beyond In Non-small Cell Lung Cancer (NSCLC): Clinical Features And Survival In A Real-world Scenario
    Ferreira, C.
    De Lima Araujo, L.
    Zukin, M.
    Alencar, F.
    Helal, R.
    Salem, J.
    Teich, N.
    Baldotto, C.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S308 - S308
  • [6] Retrospective analysis of third-line chemotherapy in advanced non-small cell lung cancer
    Tatli, Ali Murat
    Arslan, Deniz
    Uysal, Mukremin
    Goksu, Sema Sezgin
    Gunduz, Seyda Gulenay
    Coskun, Hasan Senol
    Ozdogan, Mustafa
    Savas, Burhan
    Bozcuk, Hakan Sat
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (04) : 805 - 809
  • [7] Efficacy and Toxicity of Third-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer
    Beninato, T.
    Manglaviti, S.
    Zattarin, E.
    Apollonio, G.
    Galli, E.
    Bini, M.
    Sposetti, C.
    Massa, G.
    Bottiglieri, A.
    Ganzinelli, M.
    Proto, C.
    Ferrara, R.
    Prelaj, A.
    Galli, G.
    De Toma, A.
    Brambilla, M.
    Occhipinti, M.
    De Braud, F. G. M.
    Garassino, M. C.
    Lo Russo, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1078 - S1078
  • [8] Impact of third-line chemotherapy on long-term survivors of advanced non-small cell lung cancer (NSCLC)
    Kim, T
    Kim, S
    Park, S
    Paek, J
    Choi, I
    Kim, D
    Kim, T
    Heo, D
    Bang, Y
    Kim, N
    LUNG CANCER, 2005, 49 : S252 - S253
  • [9] Treatment paradigms for patients with metastatic non-small cell lung cancer, squamous lung cancer: first second, and third-line
    Al-Farsi, Abdulaziz
    Ellis, Peter Michael
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [10] Efficacy and Safety of Amrubicin in Non-Small-Cell Lung Cancer Patients Beyond Third-Line Therapy
    Saigusa, Mika
    Asada, Kazuhiro
    Akamatsu, Taisuke
    Tanaka, Yuko
    Endo, Yoshinari
    Yamamoto, Akito
    Morita, Satoru
    Shirai, Toshihiro
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (1-2) : 52 - 56
12345